InSight sees sales and net income climb

Article

Imaging services provider InSight Health Services enjoyed higher revenues and net income for its second quarter of fiscal 1999 (end-December). The Newport Beach, CA, company attributed the growth to higher utilization of its services, as well as the

Imaging services provider InSight Health Services enjoyed higher revenues and net income for its second quarter of fiscal 1999 (end-December). The Newport Beach, CA, company attributed the growth to higher utilization of its services, as well as the impact of corporate acquisitions completed last year.

For the quarter, InSight posted sales of $38.9 million, up 33% compared with revenues of $29.1 million in the same period a year ago. The company’s net income for the most recent period was $2 million, compared with a net loss of $4.5 million in the second quarter of fiscal 1998, when InSight incurred a $6.3 million one-time charge.

InSight made four single-center acquisitions in 1998. The company’s largest deal was the purchase of mobile provider Signal Medical Services, which had revenues of $21 million in 1997, the year before it was acquired. InSight executives said that their company will continue to pursue acquisitions in 1999, and that the firm has been in discussions with several candidates. But InSight will follow through only on deals that make sense for the company, the firm said.

Recent Videos
New Mammography Studies Assess Image-Based AI Risk Models and Breast Arterial Calcification Detection
Can Deep Learning Provide a CT-Less Alternative for Attenuation Compensation with SPECT MPI?
Employing AI in Detecting Subdural Hematomas on Head CTs: An Interview with Jeremy Heit, MD, PhD
Pertinent Insights into the Imaging of Patients with Marfan Syndrome
What New Brain MRI Research Reveals About Cannabis Use and Working Memory Tasks
Current and Emerging Legislative Priorities for Radiology in 2025
How Will the New FDA Guidance Affect AI Software in Radiology?: An Interview with Nina Kottler, MD, Part 2
A Closer Look at the New Appropriate Use Criteria for Brain PET: An Interview with Phillip Kuo, MD, Part 2
How Will the New FDA Guidance Affect AI Software in Radiology?: An Interview with Nina Kottler, MD, Part 1
A Closer Look at the New Appropriate Use Criteria for Brain PET: An Interview with Phillip Kuo, MD, Part 1
Related Content
© 2025 MJH Life Sciences

All rights reserved.